Summary
Kissei Pharmaceutical Co Ltd (Kissei) discovers, manufactures and sells a range of innovative pharmaceutical products and develops. The company's pharmaceutical products include urological medicine, metabolic endocrinology medicine, drugs for kidney and dialysis department, drug for obstetrics and gynecology and ophthalmic medicine. It also develops and sells health foods including protein controlled food, energy supply food, calorie controlled food and elderly controlled food. Kissei’s research and development (R&D) activities focus on the development of novel drugs, improve existing drugs and provide superior drugs to people worldwide. The company has sales offices across Japan and an overseas subsidiary in New Jersey, the US. Kissei is headquartered in Matsumoto, Japan.
Kissei Pharmaceutical Co Ltd (4547) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Kissei Pharma and Kyorin Pharma Enter into Agreement 10
Kissei Pharma Enters into Co-Development Agreement with Ajinomoto Pharma 11
Kissei Pharma Enters into Co-Development Agreement with Alteogen for Biosimilars 12
Kissei Pharma Enters Into Co-Development Agreement With JCR Pharma 13
Licensing Agreements 14
Kissei Pharma Enters into Licensing Agreement with Vifor Fresenius Medical Care Renal Pharma 14
ObsEva Enters into Licensing Agreement with Kissei Pharma 15
Kissei Pharma Enters Into Licensing Agreement With Pfizer For KUX-1151 16
Kissei Pharma Enters Into Licensing Agreement With SpePharm For Dexrazoxane 17
AXIS Enters Into Licensing Agreement With Kissei Pharma For Pilocarpine Hydrochloride 18
BHV Pharma Enters Into Licensing Agreement With Kissei Pharma For Remogliflozin Etabonate 19
Equity Offering 20
MediciNova Completes Private Placement Of Common Stock And Preferred Stock For US$7.5 Million 20
Kissei Pharmaceutical Co Ltd - Key Competitors 22
Kissei Pharmaceutical Co Ltd - Key Employees 23
Kissei Pharmaceutical Co Ltd - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Clinical Trials 25
Oct 12, 2016: ObsEva Randomizes First Patient in Phase 2b EDELWEISS Study of OBE2109 for the Treatment of Endometriosis 25
Jul 06, 2016: ObsEva Receives Clearance from US FDA to Initiate Phase 2b Study EDELWEISS with OBE2109, a Potentially Best-in-Class Oral GnRH Antagonist, for the Treatment of Endometriosis 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27
List Of Tables
List of Tables
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Kissei Pharmaceutical Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Kissei Pharma and Kyorin Pharma Enter into Agreement 10
Kissei Pharma Enters into Co-Development Agreement with Ajinomoto Pharma 11
Kissei Pharma Enters into Co-Development Agreement with Alteogen for Biosimilars 12
Kissei Pharma Enters Into Co-Development Agreement With JCR Pharma 13
Kissei Pharma Enters into Licensing Agreement with Vifor Fresenius Medical Care Renal Pharma 14
ObsEva Enters into Licensing Agreement with Kissei Pharma 15
Kissei Pharma Enters Into Licensing Agreement With Pfizer For KUX-1151 16
Kissei Pharma Enters Into Licensing Agreement With SpePharm For Dexrazoxane 17
AXIS Enters Into Licensing Agreement With Kissei Pharma For Pilocarpine Hydrochloride 18
BHV Pharma Enters Into Licensing Agreement With Kissei Pharma For Remogliflozin Etabonate 19
MediciNova Completes Private Placement Of Common Stock And Preferred Stock For US$7.5 Million 20
Kissei Pharmaceutical Co Ltd, Key Competitors 22
Kissei Pharmaceutical Co Ltd, Key Employees 23
Kissei Pharmaceutical Co Ltd, Other Locations 24
Kissei Pharmaceutical Co Ltd, Subsidiaries 24
List Of Figures
List of Figures
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Kissei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
